Rocket


News + Filings
Holdings


All
13F
13D/G
Other

Velan Capital Investment Management LP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Morgan Adam (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC
Txns: Granted 50,000 options to buy @ $2.99, valued at $149.5k
08/17/2023 4 Morgan Adam (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC
Txns: Converted 4,845,392 shares @ $1.7, valued at $8.2M
Converted 2,924,762 shares @ $2.1, valued at $6.1M
Converted 4,178,725 shares @ $1.7, valued at $7.1M
Converted 8,117 options to buy @ $0
Converted 7,000 options to buy @ $0
Converted 6,000 options to buy @ $0
08/16/2023 SC 13D/A Velan Capital Investment Management LP reports a 26% stake in Alimera Sciences, Inc.
08/11/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/03/2023 SC 13D/A Velan Capital Investment Management LP reports a 26% stake in Alimera Sciences, Inc.
06/28/2023 SC 13D/A Velan Capital Investment Management LP reports a 4% stake in Praxis Precision Medicines, Inc.
05/19/2023 3 Velan Capital Investment Management LP (10% Owner) has filed a Form 3 on ALIMERA SCIENCES INC
05/19/2023 SC 13D/A Velan Capital Investment Management LP reports a 18.9% stake in Alimera Sciences, Inc.
05/15/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
03/31/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
03/20/2023 SC 13D Velan Capital Investment Management LP reports a 9.9% stake in Praxis Precision Medicines, Inc.
02/27/2023 SC 13D Velan Capital Investment Management LP reports a 10.2% stake in Jasper Therapeutics, Inc.
02/13/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/08/2023 3 Velan Capital Investment Management LP (See Footnote 2) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/
02/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
01/27/2023 SC 13G/A Velan Capital Investment Management LP reports a 10.2% stake in Jasper Therapeutics, Inc.
01/06/2023 SC 13G Velan Capital Investment Management LP reports a 8.8% stake in Edesa Biotech, Inc.
08/26/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
07/12/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/11/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/24/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/21/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/17/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/13/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/07/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/06/2022 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
05/25/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/24/2022 PRRN14A Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
04/18/2022 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
04/18/2022 SC 13D/A Velan Capital Investment Management LP reports a 3.3% stake in Radius Health, Inc.
03/15/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/07/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy